Why Inovio Pharmaceuticals Stock Is Soaring Today

1 min read

Shares of Inovio Pharmaceuticals (NASDAQ: INO) were soaring 19.7% higher as of 11:07 a.m. EST on Friday. The big jump came after Oppenheimer analyst Hartaj Singh initiated coverage on Inovio with an outperform rating. Singh also set a $35 price target for the stock.

It’s not a good idea to buy a biotech stock just because a Wall Street analyst likes it. However, it is a good idea to learn why an analyst is so bullish. So why does Oppenheimer’s Singh think Inovio could more than double within the next 12 months?

Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

3 Best Restaurant Stocks to Watch Right Now

Next Story

Congress May Give Tesla Buyers 400,000 More $7,000 Tax Credits

Latest from Blog